tiprankstipranks
H.C. Wainwright Sticks to Their Buy Rating for HIVE Blockchain Technologies (HIVE)
Blurbs

H.C. Wainwright Sticks to Their Buy Rating for HIVE Blockchain Technologies (HIVE)

H.C. Wainwright analyst Mike Colonnese reiterated a Buy rating on HIVE Blockchain Technologies (HIVEResearch Report) today and set a price target of $7.00. The company’s shares opened today at $4.89.

Colonnese covers the Technology sector, focusing on stocks such as Coinbase Global, Cleanspark, and Riot Platforms. According to TipRanks, Colonnese has an average return of 12.3% and a 66.67% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HIVE Blockchain Technologies with a $7.00 average price target.

See Insiders’ Hot Stocks on TipRanks >>

HIVE market cap is currently C$514.3M and has a P/E ratio of -1.81.

Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HIVE in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HIVE Blockchain Technologies Ltd. engages in building a bridge from the blockchain sector to traditional capital markets. It also involves in the production of mined cryptocurrency like Ethereum around the clock. Its project include Iceland Cryptocurrency Mining. The company was founded on June 24, 1987 and is headquartered in Vancouver, Canada.

Read More on HIVE:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles